SVG Sprites

Press

Press Releases 06.01.2021

J&J Supreme Court appeal on talc ruling “appalling”

It’s appalling, but not surprising, that Johnson & Johnson is trying to get the conservative justices on the Supreme Court to let them off the hook. This is a company that knowingly and intentionally targeted African American women with a carcinogenic product that resulted in the development of life-threatening ovarian cancer. 

Press Releases 05.28.2021

Congress must act on drug pricing reform.

For decades now, Americans have made clear that lowering the cost of prescription drugs is a key issue for them — and across party lines. 

LDPN in the News 05.27.2021

Ohio Capital Journal Opinion: To fix drug costs, stop Big Pharma price-gouging and tax-dodging

By Hannah Hendrix, American Medical Student Association

I’m studying at The Ohio State University to become a doctor because I want to help people. Unfortunately, far too many Americans today are confronting skyrocketing prescription drug costs that prevent them from following their doctor’s advice because they can’t afford treatments they need.

LDPN in the News 05.27.2021

Market Watch Opinion: Empowering Medicare to negotiate cheaper drug prices could finally break Big Pharma’s grip on our health

The Lower Drug Costs Now Act would be long-overdue step towards making prescription medicines more affordable for all Americans

By Margarida Jorge

In the thick of the coronavirus pandemic, while receiving billions in taxpayer dollars to help develop critically needed vaccines,

LDPN in the News 05.19.2021

Missoula Current Opinion: Congress should stop rewarding pharma with tax breaks for gouging patients

Love them or hate them, most Americans pay their fair share of taxes into the government’s coffers as a basic duty. In return, we get roads, schools, law enforcement, health services, clean air and water and other public goods that benefit everyone.

But for too long,

Press Releases 05.10.2021

Leading Health, Labor Organizations Call On Congress To Pass Prescription Drug Pricing Reform This Year

The national organizations leading the push for lower prescription drug prices today sent a joint letter to Congress calling on them to pass legislation to lower prescription drug prices by passing H.R. 3, the Lower Drug Costs Now Act, this year.

LDPN in the News 05.10.2021

Politico: AARP PUSHES CONGRESS TO TACKLE DRUG PRICING THIS YEAR

AARP and more than a dozen other patient advocacy organizations have signed onto a letter asking members of Congress to support H.R. 3, the House Democrats’ drug price negotiation bill.

The letter, organized by advocacy groups Lower Drug Prices Now and Patients for Affordable Drugs,

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles